The reproducibility problem has plagued biomedical science for decades, but it came into the limelight in 2012 when Amgen scientists reported that they couldn't reproduce 47 out of 53 'landmark' publications.
Reports that a drug used to treat autoimmune diseases and cancer could also treat CFS have been refuted by a new Griffith University study.
The first non-human primate trials of a dual vaccine developed in Australia for the zika and chikungunya viruses are about to begin in the United States.
How would you like to try beer that costs less and has a more consistent flavour? US scientists may have come to your rescue.
Scientists have restored visual responses in blind mice by transplanting artificial replacements for light-detecting cells into their eyes.
Adelaide researchers have developed and patented a novel approach to fight superbugs by targeting the bugs' favourite food, iron.
Zika virus could be used for treatment of glioblastoma, according to Brazilian researchers.
Australian and Dutch researchers have moved a step closer towards making human kidneys from stem cells.
Australian biomedical engineers have combined lab-made peptides with natural proteins and polymers to create a 3D 'hydrogel scaffold'.
A CRISPR-based genetic detective could lead to fast, reliable medical tests.
Researchers have identified a drug that could reverse the damaging impacts of heavy alcohol consumption on the regeneration of brain cells.
US researchers have uncovered the first evidence of a protein that can conduct electricity like a metal — so long as the voltage is high enough.
Buckingham Palace in London, the Pentagon in Virginia and the Empire State Building in New York City have something in common, reveals a new study.
Animal feed that's easier to digest. Potatoes that don't go brown. And an improved industrial oil.
A recent investigation raises concerns over poor quality, lack of regulation and misrepresentation of animal studies for drug development.